Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, ClearBridge Investments All Cap Growth. This analysis is provided for institutional research purposes only and is not investment advice.
"ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three new resilient compounders: Airbus, Linde, and Hilton."
During the fourth quarter of 2025, the ClearBridge All Cap Growth Strategy underperformed the Russell 3000 Growth Index benchmark. Performance was negatively impacted by underweight positions in mega-caps Alphabet and Apple, alongside weak selection in communication services (Netflix, Doximity) and healthcare (lack of Eli Lilly). This underperformance was partially offset by strong relative gains from Vertex, Freeport-McMoRan, and Natera. The fund initiated three new major positions during the quarter: Airbus, Linde, and Hilton. Management remains constructive on long-term AI trends but is emphasizing balance and risk-adjusted positioning as market dispersion and volatility rise.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
Growth Outlook
Market outlook remains above average conviction: ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
Risk Appetite
Risk appetite posture is moderate conviction: ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
Forward Guidance
Forward guidance signal: ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
Language Signal
Tone analysis indicates above average conviction language: ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
Perceived Risk
Perceived risk level is evaluated as above average conviction. ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
Time Horizon
Investment time horizon reflects a high conviction orientation. ClearBridge All Cap Growth Strategy lagged its benchmark in Q4 2025 due to underweight mega-cap tech positions and healthcare selection, but actively deployed capital into three ne...
